Search - tctmd.com

Displaying 1 - 20 of 65

Sort: Relevancy | Date

Presentation TCT 2025

Excision Medical

Presenter: David A. Wood

October 28, 2025

Presentation TCT 2025

How to Manage Coronary Disease with Concomitant Valve Disease

Presenter: David A. Wood

October 28, 2025

Presentation NY Valves 2025

How Much Coronary Revascularization Is Needed and When Should it Be Done?

Presenter: David A. Wood

June 27, 2025

Presentation NY Valves 2025

Introduction

Presenter: David A. Wood

June 27, 2025

Presentation TCT 2024

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

Presenter: David Wood

October 30, 2024

Presentation TCT 2024

How do I plan and prepare for TAV-in-TAV-in-SAV?

Presenter: David Wood

October 29, 2024

Presentation NY Valves 2024

Access Disparities Affecting Appropriate AS Therapy

Presenter: David A. Wood

June 07, 2024

Presentation NY Valves 2024

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Presenter: David A. Wood

June 06, 2024

Presentation NY Valves 2024

Case Presentation 1: TAVR in Bicuspid AS with BEV

Presenter: David A. Wood

June 05, 2024

Presentation TCT 2023

Staged NCL PCI Is Safer and Better for the Patient!

Presenter: David Wood

October 25, 2023

Presentation TVT 2023

Position 2: Echo Overestimates Bioprosthetic Valve Gradients Following TAVR. Always Confirm With Invasive Assessment

Presenter: David Wood

June 08, 2023

Presentation TCT 2022

Why are Hemodynamics so Important During TAVR?

Presenter: David Wood

September 18, 2022

Presentation TCT 2022

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

Presenter: David Wood

September 17, 2022

Presentation TVT 2022

Management of CAD in TAVR: Treat Before, During, After, OR Not at All (COMPLETE TAVR Updates)

Presenter: David Wood

June 09, 2022

Presentation TVT 2022

An Algorithm for Managing High Echo Gradients After TAVR

Presenter: David Wood

June 09, 2022

Presentation TCT 2021

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

Presenter: David Wood

November 06, 2021

Presentation TCT 2019

COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing

Presenter: David Wood

September 28, 2019

Presentation TCT 2019

Minimalist TAVR for Everyone: Safe, Efficient, and Cost-Effective

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

Large-Hole Transfemoral Closure III: The MANTA Device

Presenter: David Wood

September 27, 2019

Presentation TCT 2019

Upcoming Closure Device System Dedicated to Large-Bore Procedure

Presenter: David Wood

September 27, 2019

Advertisement

Excision Medical

How to Manage Coronary Disease with Concomitant Valve Disease

How Much Coronary Revascularization Is Needed and When Should it Be Done?

Introduction

The Impact of Access Disparities on Appropriate AS Therapy and Clinical Outcomes

How do I plan and prepare for TAV-in-TAV-in-SAV?

Access Disparities Affecting Appropriate AS Therapy

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Case Presentation 1: TAVR in Bicuspid AS with BEV

Staged NCL PCI Is Safer and Better for the Patient!

Position 2: Echo Overestimates Bioprosthetic Valve Gradients Following TAVR. Always Confirm With Invasive Assessment

Why are Hemodynamics so Important During TAVR?

Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?

Management of CAD in TAVR: Treat Before, During, After, OR Not at All (COMPLETE TAVR Updates)

An Algorithm for Managing High Echo Gradients After TAVR

Prosthetic Valve Selection and Implant Techniques for Prevention of PPM/High Residual Gradients Following SAVR, TAVR, or Valve-in-Valve

COMPLETE Timing Substudy: A Randomized Trial of Complete Staged Revascularization vs. Infarct Artery PCI Alone in Patients With Acute Myocardial Infarction and Multivessel Disease — Importance of Revascularization Timing

Minimalist TAVR for Everyone: Safe, Efficient, and Cost-Effective

Large-Hole Transfemoral Closure III: The MANTA Device

Upcoming Closure Device System Dedicated to Large-Bore Procedure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content